BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7128694)

  • 1. Angiotensin stimulates oxytocin release: imparied response in rats with genetic hypothalamic diabetes insipidus.
    Lang RE; Rascher W; Heil J; Unger T; Ganten D
    Eur J Pharmacol; 1982 Sep; 83(1-2):113-7. PubMed ID: 7128694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin stimulates oxytocin release: impaired response in rats with genetic hypothalamic diabetes insipidus.
    Lang RE; Rascher W; Heil J; Unger T; Ganten D
    Ann N Y Acad Sci; 1982; 394():147-52. PubMed ID: 6960752
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulation of hypothalamic magnocellular neuropeptides and their mRNAs in the Brattleboro rat: coordinate responses to further osmotic challenge.
    Sherman TG; Day R; Civelli O; Douglass J; Herbert E; Akil H; Watson SJ
    J Neurosci; 1988 Oct; 8(10):3785-96. PubMed ID: 2903913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous vasopressin modulates activity of oxytocin neurons in homozygous Brattleboro rats.
    Cheng SW; North WG
    Am J Physiol; 1986 Nov; 251(5 Pt 1):E556-62. PubMed ID: 3777164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exogenous central angiotensin fails to stimulate a sodium appetite in diabetes insipidus Brattleboro rats.
    St O; B B; B O; B F; Lemamy GJ; B N; J M; Sn T
    Physiol Behav; 2021 Mar; 230():113308. PubMed ID: 33387586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial natriuretic peptide in dehydrated Long-Evans rats and Brattleboro rats.
    Ogawa K; Henry MA; Tange J; Woodcock EA; Johnston CI
    Kidney Int; 1987 Mar; 31(3):760-5. PubMed ID: 2952831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salt and water intake in Brattleboro rats with hypothalamic diabetes insipidus.
    Elfont RM; Sokol HW
    Physiol Behav; 1987; 39(1):53-61. PubMed ID: 3562652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of endogenous vasopressin in development of gastric ulcer induced by restraint and water immersion.
    Honda K; Fukuda S; Ishikawa SE; Kuzuya T; Saito T
    Am J Physiol; 1994 May; 266(5 Pt 2):R1448-53. PubMed ID: 8203619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The vasopressin-associated glycopeptide is not a prolactin-releasing factor: studies with lactating Brattleboro rats.
    Hyde JF; North WG; Ben-Jonathan N
    Endocrinology; 1989 Jul; 125(1):35-40. PubMed ID: 2500328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desensitization of rat renal thick ascending limb cells to vasopressin.
    Elalouf JM; Sari DC; Roinel N; de Rouffignac C
    Proc Natl Acad Sci U S A; 1988 Apr; 85(7):2407-11. PubMed ID: 3353389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II-induced vasopressin release is mediated through alpha-1 adrenoceptors and angiotensin II AT1 receptors in the supraoptic nucleus.
    Qadri F; Culman J; Veltmar A; Maas K; Rascher W; Unger T
    J Pharmacol Exp Ther; 1993 Nov; 267(2):567-74. PubMed ID: 8246129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High, vasopressin-reversible, immunoreactive somatostatin in specific hypothalamic nuclei of rats with diabetes insipidus (Brattleboro rats).
    Saavedra JM; Rougeot C; Chevillard C; Dray F
    Brain Res; 1983 Oct; 277(1):23-30. PubMed ID: 6139144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of prolonged vasopressin treatment in Brattleboro rats with diabetes insipidus.
    Möhring J; Kohrs G; Möhring B; Petri M; Homsy E; Haack D
    Am J Physiol; 1978 Feb; 234(2):F106-11. PubMed ID: 623299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasopressin reduces release from vasopressin-neurons and oxytocin-neurons by acting on V2-like receptors.
    Cheng SW; North WG
    Brain Res; 1989 Feb; 479(1):35-9. PubMed ID: 2522339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular effects of arginine vasopressin during fluid deprivation in the rat.
    Aisenbrey GA; Handelman WA; Arnold P; Manning M; Schrier RW
    J Clin Invest; 1981 Apr; 67(4):961-8. PubMed ID: 7204578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pressor action of centrally perfused angiotensin II in rats with hereditary hypothalamic diabetes insipidus.
    Hutchinson JS; Schelling P; Möhring J; Ganten D
    Endocrinology; 1976 Sep; 99(3):819-23. PubMed ID: 954671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central nitric oxide blocks vasopressin, oxytocin and atrial natriuretic peptide release and antidiuretic and natriuretic responses induced by central angiotensin II in conscious rats.
    Reis WL; Giusti-Paiva A; Ventura RR; Margatho LO; Gomes DA; Elias LL; Antunes-Rodrigues J
    Exp Physiol; 2007 Sep; 92(5):903-11. PubMed ID: 17513344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contractile effect and tissue content of arginine vasopressin in the urinary bladder of Brattleboro rats with hereditary diabetes insipidus.
    Uvelius B; Lundin S; Andersson KE
    Gen Pharmacol; 1992 Jul; 23(4):591-4. PubMed ID: 1397966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A hypothalamic dysfunction--diabetes insipidus in (Brattleboro) rats and the mutation in the vasopressin gene.
    Richter D
    Adv Biochem Psychopharmacol; 1987; 43():13-9. PubMed ID: 3591511
    [No Abstract]   [Full Text] [Related]  

  • 20. Angiotensin immunoreactivity in vasopressin cells in rat hypothalamus and its relative deficiency in homozygous Brattleboro rats.
    Hoffman DL; Krupp L; Schrag D; Nilaver G; Valiquette G; Kilcoyne MM; Zimmerman EA
    Ann N Y Acad Sci; 1982; 394():135-41. PubMed ID: 6758645
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.